Results 61 to 70 of about 212 (104)
Mapping the research landscape of antibody therapy for Ebola virus disease: a bibliometric analysis
BackgroundAntibody-based therapies have become a cornerstone of Ebola virus disease (EVD) treatment and prevention, particularly following the successful clinical development of monoclonal antibody therapeutics against Zaire ebolavirus.
Zengwei Kou +6 more
doaj +1 more source
Serologic Evidence of Fruit Bat Exposure to Filoviruses, Singapore, 2011–2016
To determine whether fruit bats in Singapore have been exposed to filoviruses, we screened 409 serum samples from bats of 3 species by using a multiplex assay that detects antibodies against filoviruses.
Eric D. Laing +14 more
doaj +1 more source
Vaccine preparedness for Bundibugyo virus and lessons learned
The ongoing 2026 outbreak of Bundibugyo virus (BDBV) in the Democratic Republic of the Congo and Uganda is the largest so far on record. Despite experience from previous Ebolavirus outbreaks, the current lack of vaccines against BDBV underscores a ...
Michel Pletschette, Nadine Biedenkopf
doaj +1 more source
Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017–2019
Although pigs are naturally susceptible to Reston virus and experimentally to Ebola virus (EBOV), their role in Orthoebolavirus ecology remains unknown.
Solène Grayo +10 more
doaj +1 more source
Following the Bundibugyo virus disease outbreak reported in the Democratic Republic of the Congo in May 2026, we reviewed all known Ebola disease cases outside Africa and found that intercontinental transmission risk remains low.
Nicholas G Davies
doaj +1 more source
The 2026 Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda has prompted European countries and the United States to revise measures for travellers, healthcare workers and humanitarian personnel returning from ...
and of the ESCMID Emerging Infection Subcommittee
doaj +1 more source
Summary: Previous work demonstrates that ebolaviruses can spread to neighboring cells through intercellular connections. Here, we present a protocol to quantify the intercellular spread of ebolaviruses via immunofluorescence.
Rodrigo I. Santos, Alexander Bukreyev
doaj +1 more source
Serologic evidence of orthomarburgviruses and an orthoebolavirus in frugivorous Malagasy bats
Recent outbreaks of Marburg virus disease in regions of sub-Saharan Africa without prior record such as Ghana, Tanzania, Equatorial Guinea, and Rwanda challenge the current understanding of areas at-risk for filovirus spillover.
Marana S. Rekedal +14 more
doaj +1 more source
Case fatality rate for Ebola disease, 1976–2022: A meta-analysis of global data
An up-to-date pooled case fatality rate (CFR) for Ebola disease (EBOD) at the global level is lacking. We abstracted EBOD data from 1976 to 2022 for 16 countries and 42 outbreaks to conduct a meta-analysis.
Jonathan Izudi, Francis Bajunirwe
doaj +1 more source

